14:00-14:30 Registration and networking
14:30-14:35 Introductory remarks by moderator
14:35-15:10 Introductory remarks by speakers
15:10-16:10 Panel Discussion and Q&A
16:10-17:00 Networking
Partner, Eubelius
Joris obtained his Master of Laws degree at the Vrije Universiteit Brussel (VUB). He assisted Ekopak on its initial listing on Euronext Brussels and private placement of €56.6 million (2021), and Hyloris Pharmaceuticals on its initial public offering (IPO) of €62 million (2020). He also assisted Xior Student Housing and Mithra Pharmaceuticals with their initial listing on Euronext Brussels and their preceding corporate reorganisations (2015). Furthermore, he assisted a large number of Belgian public regulated real estate companies (BE-REITs) and biotech companies on their public and private capital increases in the past few years. Joris assisted the Adecco group on its €2 billion combination with AKKA Technologies and 3D on its public takeover bid for Zenitel (2021). He also assisted Giled Sciences on its $5.1 billion Transformative R&D Collaboration with Galapagos (2019). He advised Ablynx on its defence against the hostile approach by Novo Nordisk and its subsequent support for the €3.9 billion public tender offer by Sanofi (2018), and he assisted Vastned Retail Nederland on its €100 million contemplated public takeover bid for Vastned Retail Belgium (BE-REIT) (2018). Joris advised Bain Capital Private Equity on the proposed €390 million public takeover bid for Resilux (2017), and he assisted BEVCO (Santo Domingo family) with the Belgian aspects of the combination of AB InBev and SAB Miller (2016). Joris teaches about listed companies as a guest lecturer at the Jan Ronse Institute for Company and Financial Law (KU Leuven). For several year, he was also corporate law assistant at the same institute and at the UHasselt until his mandate ended in 2017. He makes regular contributions to specialised publications and gives lectures on corporate and financial law. He handles cases in Dutch, English and French.
Already registered?
If you have registered for this event, you should have received an email containing an access code. Please be sure to check your spam folder as well. If you have any further questions or concerns, please do not hesitate to reach out to us at info@qed.eu.